Kiora Pharmaceuticals (KPRX)
(Real Time Quote from BATS)
$4.18 USD
-0.05 (-1.18%)
Updated Jul 15, 2024 11:46 AM ET
2-Buy of 5 2
A Value A Growth C Momentum A VGM
Cash flow Statements
Fiscal Year End for Kiora Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -12.51 | -13.58 | -16.39 | -8.09 | -7.10 |
Depreciation/Amortization & Depletion | 0.05 | 0.04 | 6.31 | 0.03 | 0.05 |
Net Change from Assets/Liabilities | -1.82 | 0.67 | -1.04 | -0.32 | -2.72 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.73 | 2.45 | 0.23 | 1.06 | 1.61 |
Net Cash From Operating Activities | -9.56 | -10.43 | -10.89 | -7.32 | -8.15 |
Property & Equipment | 0.00 | 0.01 | -0.06 | -0.02 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -0.09 | -0.11 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | -0.11 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.01 | -0.16 | -0.24 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 5.60 | 8.62 | 18.80 | 0.22 | 2.15 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.28 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.37 | 0.00 | -1.00 | 4.50 | 1.78 |
Net Cash from Financing Activities | 5.97 | 8.62 | 17.80 | 5.00 | 3.92 |
Effect of Exchange Rate Changes | 0.04 | -0.09 | -0.08 | -0.03 | 0.01 |
Net Change In Cash & Equivalents | -3.55 | -1.89 | 6.67 | -2.59 | -4.23 |
Cash at Beginning of Period | 6.01 | 7.90 | 1.23 | 3.82 | 8.05 |
Cash at End of Period | 2.46 | 6.01 | 7.90 | 1.23 | 3.82 |
Diluted Net EPS | -24.21 | -166.97 | -637.26 | -637.26 | -802.88 |
Fiscal Year End for Kiora Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 13.45 | -12.51 | -10.25 | -4.48 |
Depreciation/Amortization & Depletion | NA | 0.00 | 0.05 | 0.04 | 0.03 |
Net Change from Assets/Liabilities | NA | -0.01 | -1.82 | -1.22 | -0.73 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.17 | 4.73 | 4.44 | 0.73 |
Net Cash From Operating Activities | NA | 13.62 | -9.56 | -6.98 | -4.45 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 1.44 | 5.60 | 6.62 | 6.62 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.44 | 0.44 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 13.81 | 0.37 | -0.61 | -0.61 |
Net Cash from Financing Activities | NA | 15.25 | 5.97 | 6.45 | 6.45 |
Effect of Exchange Rate Changes | NA | -0.05 | 0.04 | -0.09 | -0.06 |
Net Change In Cash & Equivalents | NA | 28.82 | -3.55 | -0.61 | 1.94 |
Cash at Beginning of Period | NA | 2.46 | 6.01 | 6.01 | 6.01 |
Cash at End of Period | NA | 31.28 | 2.46 | 5.40 | 7.96 |
Diluted Net EPS | NA | 3.42 | -0.09 | -8.01 | -7.11 |